FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048893870> ?p ?o ?g. }

• W3048893870 endingPage "804" @default.
• W3048893870 startingPage "794" @default.
• W3048893870 abstract "Methotrexate (MTX) is a water-insoluble, anti-tumor agent that causes adverse effects like bone marrow suppression, chronic interstitial obstructive pulmonary disease, hepatotoxicity, leukopenia, interstitial pneumonitis and nephrotoxicity with slow drug release rate.The present study aimed to successfully incorporate MTX into novel-targeted Pluronic (PEOPPO- PEO tri-block co-polymer) F127 polymeric micelles intended for intravenous administration with improved drug loading and sustained release behavior necessary to achieve better efficacy of MTX.MTX-loaded Pluronic F127 micelles were characterized for critical micelle concentration, particle size and zeta potential,1H NMR, drug loading, encapsulation efficiency characterization, cell uptake, in vitro release study along with partition coefficient and solubilization thermodynamics.The micellar formulation resulted in nano size 27.32±1.43nm of PF127/SDS, as compared to Pluronic F127 micelles or PF127/Phosphatidyl choline which were 30.52±1.18nm and 154.35±5.5nm in size, respectively. The uptake of PF127/SDS micellar formulation incorporating Rhodamine 123 in MCF7 cancer cells was found to be higher (84.25%) than PF127/PC, PF127 and MTX i.e. 66.26%, 73.59% and 53% respectively. The in vitro MTX release from PF127, PF127/SDS and PF127/PC polymeric micelles formulations was observed to be 69%, 69.5% and 66% at 12 h whereas 80.89%, 77.67% and 78.54% after 24 h, respectively and revealed a sustained release. MTX-loaded PF127/SDS micelles showed high partition coefficient and negative free energy of solubilization compared to PF127 and PF127/PC which signify self-assembly behavior and thermodynamic stability towards higher dissociation.It was finally concluded that MTX-loaded PF127/SDS micelles act as a potential anticancer delivery system in comparison to PF127/PC and PF127 to combat tumor cells by enhancing their cellular uptake targeting with sustained release pattern and reducing the thermodynamic instability. Thus, PF127/SDS micellar formulation can provide a useful alternative dosage form for intravenous administration of MTX." @default.
• W3048893870 created "2020-08-18" @default.
• W3048893870 creator A5032025678 @default.
• W3048893870 creator A5037737796 @default.
• W3048893870 creator A5091887964 @default.
• W3048893870 date "2021-09-20" @default.
• W3048893870 modified "2023-09-27" @default.
• W3048893870 title "Self-Assemble Amphiphilic PEO-PPO-PEO Tri-Block Co-Polymeric Methotrexate Nanomicelles to Combat MCF7 Cancer Cells" @default.
• W3048893870 cites W102575954 @default.
• W3048893870 cites W1567645277 @default.
• W3048893870 cites W1965443653 @default.
• W3048893870 cites W1965910946 @default.
• W3048893870 cites W1983408077 @default.
• W3048893870 cites W1984336617 @default.
• W3048893870 cites W1985631236 @default.
• W3048893870 cites W1988941884 @default.
• W3048893870 cites W1991092566 @default.
• W3048893870 cites W1993845273 @default.
• W3048893870 cites W1994688369 @default.
• W3048893870 cites W1995995697 @default.
• W3048893870 cites W1996701312 @default.
• W3048893870 cites W2000658239 @default.
• W3048893870 cites W2008272181 @default.
• W3048893870 cites W2015346163 @default.
• W3048893870 cites W2026849618 @default.
• W3048893870 cites W2033817602 @default.
• W3048893870 cites W2034299145 @default.
• W3048893870 cites W2036459378 @default.
• W3048893870 cites W2044673043 @default.
• W3048893870 cites W2061106944 @default.
• W3048893870 cites W2061906593 @default.
• W3048893870 cites W2063132329 @default.
• W3048893870 cites W2065667184 @default.
• W3048893870 cites W2069318561 @default.
• W3048893870 cites W2082587127 @default.
• W3048893870 cites W2120377744 @default.
• W3048893870 cites W2124862062 @default.
• W3048893870 cites W2132116581 @default.
• W3048893870 cites W2145362882 @default.
• W3048893870 cites W2149493846 @default.
• W3048893870 cites W2313374574 @default.
• W3048893870 cites W2488409378 @default.
• W3048893870 cites W2615578920 @default.
• W3048893870 cites W2746236721 @default.
• W3048893870 cites W2791765980 @default.
• W3048893870 cites W2933720053 @default.
• W3048893870 cites W2966963881 @default.
• W3048893870 cites W2987324118 @default.
• W3048893870 cites W3005713586 @default.
• W3048893870 cites W3009136940 @default.
• W3048893870 cites W3020874473 @default.
• W3048893870 cites W326271711 @default.
• W3048893870 doi "https://doi.org/10.2174/1567201817666200810110914" @default.
• W3048893870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32778025" @default.
• W3048893870 hasPublicationYear "2021" @default.
• W3048893870 type Work @default.
• W3048893870 sameAs 3048893870 @default.
• W3048893870 citedByCount "4" @default.
• W3048893870 countsByYear W30488938702022 @default.
• W3048893870 countsByYear W30488938702023 @default.
• W3048893870 crossrefType "journal-article" @default.
• W3048893870 hasAuthorship W3048893870A5032025678 @default.
• W3048893870 hasAuthorship W3048893870A5037737796 @default.
• W3048893870 hasAuthorship W3048893870A5091887964 @default.
• W3048893870 hasConcept C101335993 @default.
• W3048893870 hasConcept C11268172 @default.
• W3048893870 hasConcept C13965031 @default.
• W3048893870 hasConcept C15920480 @default.
• W3048893870 hasConcept C178790620 @default.
• W3048893870 hasConcept C184651966 @default.
• W3048893870 hasConcept C185592680 @default.
• W3048893870 hasConcept C521977710 @default.
• W3048893870 hasConcept C64237528 @default.
• W3048893870 hasConcept C71924100 @default.
• W3048893870 hasConcept C92912615 @default.
• W3048893870 hasConcept C98274493 @default.
• W3048893870 hasConceptScore W3048893870C101335993 @default.
• W3048893870 hasConceptScore W3048893870C11268172 @default.
• W3048893870 hasConceptScore W3048893870C13965031 @default.
• W3048893870 hasConceptScore W3048893870C15920480 @default.
• W3048893870 hasConceptScore W3048893870C178790620 @default.
• W3048893870 hasConceptScore W3048893870C184651966 @default.
• W3048893870 hasConceptScore W3048893870C185592680 @default.
• W3048893870 hasConceptScore W3048893870C521977710 @default.
• W3048893870 hasConceptScore W3048893870C64237528 @default.
• W3048893870 hasConceptScore W3048893870C71924100 @default.
• W3048893870 hasConceptScore W3048893870C92912615 @default.
• W3048893870 hasConceptScore W3048893870C98274493 @default.
• W3048893870 hasIssue "6" @default.
• W3048893870 hasLocation W30488938701 @default.
• W3048893870 hasLocation W30488938702 @default.
• W3048893870 hasOpenAccess W3048893870 @default.
• W3048893870 hasPrimaryLocation W30488938701 @default.
• W3048893870 hasRelatedWork W1978466251 @default.
• W3048893870 hasRelatedWork W1986952063 @default.
• W3048893870 hasRelatedWork W1991712338 @default.
• W3048893870 hasRelatedWork W2094313147 @default.
• W3048893870 hasRelatedWork W2312240133 @default.

• next